Table 1.
Post-Treatment Mean (se) | ANOVA (Condition) | ||||
---|---|---|---|---|---|
|
|||||
Measure | Transdiagnostic | Dx-Specific | F | p | partial η2 |
CSR | 3.15 (0.38) | 2.97 (0.42) | 0.12 | .73 | .004 |
CGI-S | 2.91 (0.26) | 3.20 (0.29) | 0.44 | .51 | .017 |
CGI-I | 2.25 (0.19) | 2.08 (0.21) | 0.32 | .57 | .011 |
PDSS | 5.25 (1.00) | 7.28 (1.00) | 1.47 | .24 | .052 |
SPDQ | 11.96 (1.48) | 9.90 (1.29) | 1.10 | .31 | .052 |
GADQ | 15.01 (1.95) | 16.19 (1.81) | 0.19 | .67 | .008 |
BDI | 8.69 (2.06) | 11.24 (2.06) | 0.76 | .39 | .027 |
STAI (Slope) | −0.98 (0.09) | −1.01 (0.10) | 0.05 | .83 | .001 |
Notes: Means represent post-treatment estimated marginal means (standard error) after controlling for pre-treatment scores for each condition. For each measure, more positive scores represent greater anxiety severity.
CSR: Clinician Severity Ratings of principal diagnosis; CGI-S: Clinical Global Impressions scale – Severity; CGI-I: Clinical Global Impressions scale – Improvement; PDSS: Panic Disorder Severity Scale; SPDQ: Social Phobia Diagnostic Questionnaire; GADQ: Generalized Anxiety Disorder Questionnaire; STAI (Slope): State-Trait Anxiety Inventory (State version) slopes from mixed-effect regression model.